Bruker (BRKR) Tops Q1 EPS by 5c, Beats on Revenue; Offers FY25 Guidance

Bruker (NASDAQ: BRKR) reported Q1 EPS of $0.47, $0.05 better than the analyst estimate of $0.42. Revenue for the quarter came in at $801.4 million versus the consensus estimate of $764.72 million.

GUIDANCE:

Bruker sees FY2025 EPS of $2.40-$2.48, versus the consensus of $2.63. Bruker sees FY2025 revenue of $3.48-3.55 billion, versus the consensus of $3.48 billion.

For earnings history and earnings-related data on Bruker (BRKR) click here.

You May Also Be Interested In

• AutoZone (AZO) Tops Q4 EPS by $1.76, Misses on Revenue
• Canaccord Reiterates Hold Rating on Yeti Holdings Inc. (YETI)
• Castle Biosciences opens 55,000-sq-ft lab in Scottsdale, Arizona